logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

Zhejiang Huahai In-licenses Immuno-Oncology Drug in $65 Million Deal

Nov 8, 2017

Life Science

China’s EOC raises $32M to build on crop of harvested cancer drugs

Nov 7, 2017

Life Science

DelMar Pharmaceuticals Inc NASDAQ:DMPI

DelMar Pharmaceuticals Appoints Saiid Zarrabian as Interim Chief Executive Officer

Nov 7, 2017

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Appoints Douglas Mason To the Board of Directors

Nov 7, 2017

Life Science

WuXi AppTec Joins $28M Round In Chinese Precision Medicine Firm AnchorDX

Nov 7, 2017

Life Science

Luye Pharm Leads $11.2 Million Funding of Chicago’s Exicure

Nov 7, 2017

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

CBD Products Final Approval for Japan Distribution: Ambarii Corp Providing Naturally Splendid USA HempOmega(TM) Infused Samples

Nov 6, 2017

Life Science

WuXi Biologics Partners with Pall to Reduce mAb Production Costs

Nov 4, 2017

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Closes Second Tranche with Alumina Partners Ltd.

Nov 3, 2017

Life Science

Annoroad, a Beijing Gene Services Company, Raises $100 Million in C Round

Nov 3, 2017

Life Science

Lexaria Bioscience CSE:LXX Biotechnology, Cannabis, 生物科技,大麻

Lexaria Bioscience Acquires 100% Ownership of Poviva Tea LLC.

Nov 2, 2017

Life Science

World’s Largest Generic Drug Maker Seeks Tie Up With Producer of Chinese Viagra – Bloomberg

Nov 2, 2017

Life Science

VolitionRX Ltd NYSE:VNRX

VolitionRx Limited Schedules Third Quarter 2017 Earnings Conference Call and Business Update

Nov 2, 2017

Life Science

NAI500 Investment Destination Series – Learn about Investment in Vancouver Part 3: Life Science Sector

Nov 2, 2017

Life Science, Technology

NAI500 Life Science & Technology Weekly Issue 119 – AU, China’s ZTE Launch Smart Health System Project

Nov 2, 2017

Life Science, Technology

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药,生物科技

Resverlogix Announces Participation in Upcoming Conferences

Nov 2, 2017

Life Science, Technology

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Canadian Ambassador to South Korea Visits Naturally Splendid Facility

Nov 2, 2017

Life Science, Technology

Redhill Biopharma Ltd NASDAQ:RDHL Pharmaceutical, Biotechnology,医药,生物科技

RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines

Nov 2, 2017

Life Science, Technology

  • ‹‹ Previous
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada